JPH2 p.(Thr161Lys) is a Finnish founder mutation associating to hypertrophic cardiomyopathy with or without systolic heart failure and conduction abnormalities
28 August 2018 (14:00 - 18:00)
Organised by:
Abstract
About the speaker

Turku University Hospital, Turku (Finland)
13 More presentations in this session
Access the full session
The Event
ESC Congress 2018
28 August 2018
14:00 CET
